Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tuesday, July 22, 2025 1 min read
Key Takeaway: Dr. Oliver Sartor has been appointed to the Scientific Advisory Board of Radiopharm. His extensive experience in oncology and theranostics is expected to contribute positively to the company's strategic initiatives. This appointment aligns with Radiopharm's focus on advancing its clinical programs and enhancing its research capabilities.
Price reaction · baseline $4.41 (2025-07-22 close) · hit after-hours · 1 other RADX headline(s) in the window, move may be shared
day 0 close
+5.1%
day 1 · peak
+8.2%
day 3
+7.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Oliver Sartor brings significant expertise to the advisory board.
  • The appointment may enhance Radiopharm's strategic direction.
  • Sartor's involvement could lead to innovative developments in theranostics.

Full Press Release Details

• Announcements , Updates
• PDF
• July 22, 2025
Loading Viewer…

More Announcements & Updates

• Announcements
• April 28, 2022
• Announcements
• November 27, 2024
• Announcements
• December 22, 2023
• Announcements
• June 25, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

Who is Dr. Oliver Sartor?

Dr. Oliver Sartor is a renowned expert in oncology and theranostics.

What role will Dr. Sartor play at Radiopharm?

He will serve on the Scientific Advisory Board, guiding strategic initiatives.

Why is Dr. Sartor's appointment significant?

His expertise is expected to enhance Radiopharm's clinical and research efforts.

What is Radiopharm's focus?

Radiopharm focuses on advancing theranostics and clinical programs.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Dr. Oliver Sartor Scientific Advisory Board theranostics clinical programs
Last updated: Jul 22, 2025